TScan Therapeutics (TCRX) EBITDA Margin (2020 - 2026)
TScan Therapeutics (TCRX) recorded EBITDA Margin of -5520.99% in Q3 2026, down 4075.95 percentage points from -1445.04% a year earlier and down 2686.17 percentage points from the prior quarter.
TScan Therapeutics (TCRX) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, TScan Therapeutics' EBITDA Margin came in at -2192.98% as of Sep 30, 2026, down 461.85 percentage points year-over-year; for FY2025, it was -1287.29%, up 3354.79 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +1019.90 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -4642.08% in FY2024 (-4223.73 pp), -418.35% in FY2023 (+36.30 pp), -454.64% in FY2022 (-7.54 pp) and -447.11% in FY2021 (+1860.08 pp).
- The Q3 2026 figure is the lowest quarterly EBITDA Margin since Q2 2024.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of +325.95 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 4922.44 percentage points in Q2 2025, against a drop of 5415.75 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -2834.82% (Q2 2026), -2896.74% (Q1 2026) and -901.25% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -883.96% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 36.69% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 32.68% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 46.88% |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 40.60% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 50.63% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | -5,520.99% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -5,520.99% |
| Jun 30, 2026 | -2,834.82% |
| Mar 31, 2026 | -2,896.74% |
| Dec 31, 2025 | -901.25% |
| Sep 30, 2025 | -1,445.04% |
| Jun 30, 2025 | -1,233.91% |
| Mar 31, 2025 | -1,638.51% |
| Dec 31, 2024 | -5,413.68% |
| Sep 30, 2024 | -3,011.92% |
| Jun 30, 2024 | -6,156.34% |
| Mar 31, 2024 | -5,321.38% |
| Dec 31, 2023 | -271.78% |
| Sep 30, 2023 | -603.60% |
| Jun 30, 2023 | -740.60% |
| Mar 31, 2023 | -312.27% |
| Dec 31, 2022 | -537.64% |
| Sep 30, 2022 | -455.75% |
| Jun 30, 2022 | -346.13% |
| Mar 31, 2022 | -495.47% |
| Dec 31, 2021 | -457.60% |
TScan Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();